{"title":"Stimulation cérébrale profonde dans le syndrome de Gilles de la Tourette","authors":"Yulia Worbe","doi":"10.1016/j.banm.2026.03.019","DOIUrl":null,"url":null,"abstract":"<div><div>Gilles de la Tourette syndrome (GTS) is a neurodevelopmental disorder characterized by the presence of motor and vocal tics, frequently associated with psychiatric comorbidities, including obsessive–compulsive disorder, attention-deficit/hyperactivity disorder, and mood and anxiety disorders. Over the past decades, major advances have reshaped our understanding of the pathophysiology of GTS. Neuropathological, transcriptomic, and developmental studies now converge toward the presence of a marked deficit in striatal interneurons, arising from early disruptions in signaling pathways involved in basal ganglia development. This interneuronal loss leads to an imbalance between inhibitory and excitatory processes, impairing the selection and filtering of motor programs within cortico–striato–thalamo–cortical circuits. Therapeutic management of GTS follows a stepwise approach, with behavioral interventions and pharmacological treatments as first-line strategies. However, deep brain stimulation (DBS) has emerged as a last-resort therapeutic option for a small subset of patients with severe, disabling, and treatment-refractory forms of the disorder. Patient selection, as defined by the European Society for the Study of Tourette Syndrome (ESSTS) guidelines, relies on a rigorous multidisciplinary assessment encompassing tic severity, functional impairment, and stability of psychiatric comorbidities. While controlled clinical trials have supported the relevance of thalamic targets, particularly the centromedian–parafascicular complex, and pallidal targets such as the globus pallidus internus, recent research has shifted toward a network-based perspective and the characterization of oscillatory dynamics underlying tic generation. Although continuous open-loop stimulation remains the current clinical standard, cutting-edge research is now focusing on adaptive neuromodulation strategies. By leveraging the decoding of local field potentials (LFPs), feasibility studies have demonstrated the long-term stability of electrophysiological biomarkers, paving the way for personalized, real-time stimulation paradigms. These developments hold promise for optimizing the benefit–risk balance of DBS in the most complex and severely affected patients with GTS.</div></div>","PeriodicalId":55317,"journal":{"name":"Bulletin De L Academie Nationale De Medecine","volume":"210 8","pages":"Pages 933-938"},"PeriodicalIF":0.3000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin De L Academie Nationale De Medecine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0001407926002797","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Gilles de la Tourette syndrome (GTS) is a neurodevelopmental disorder characterized by the presence of motor and vocal tics, frequently associated with psychiatric comorbidities, including obsessive–compulsive disorder, attention-deficit/hyperactivity disorder, and mood and anxiety disorders. Over the past decades, major advances have reshaped our understanding of the pathophysiology of GTS. Neuropathological, transcriptomic, and developmental studies now converge toward the presence of a marked deficit in striatal interneurons, arising from early disruptions in signaling pathways involved in basal ganglia development. This interneuronal loss leads to an imbalance between inhibitory and excitatory processes, impairing the selection and filtering of motor programs within cortico–striato–thalamo–cortical circuits. Therapeutic management of GTS follows a stepwise approach, with behavioral interventions and pharmacological treatments as first-line strategies. However, deep brain stimulation (DBS) has emerged as a last-resort therapeutic option for a small subset of patients with severe, disabling, and treatment-refractory forms of the disorder. Patient selection, as defined by the European Society for the Study of Tourette Syndrome (ESSTS) guidelines, relies on a rigorous multidisciplinary assessment encompassing tic severity, functional impairment, and stability of psychiatric comorbidities. While controlled clinical trials have supported the relevance of thalamic targets, particularly the centromedian–parafascicular complex, and pallidal targets such as the globus pallidus internus, recent research has shifted toward a network-based perspective and the characterization of oscillatory dynamics underlying tic generation. Although continuous open-loop stimulation remains the current clinical standard, cutting-edge research is now focusing on adaptive neuromodulation strategies. By leveraging the decoding of local field potentials (LFPs), feasibility studies have demonstrated the long-term stability of electrophysiological biomarkers, paving the way for personalized, real-time stimulation paradigms. These developments hold promise for optimizing the benefit–risk balance of DBS in the most complex and severely affected patients with GTS.
图雷特Gilles de la Tourette综合征(GTS)是一种以运动和声音抽搐为特征的神经发育障碍,常伴有精神合并症,包括强迫症、注意力缺陷/多动障碍、情绪和焦虑障碍。在过去的几十年里,重大进展重塑了我们对GTS病理生理学的理解。神经病理学、转录组学和发育研究现在都集中在纹状体中间神经元中存在明显的缺陷,这是由参与基底神经节发育的信号通路的早期中断引起的。这种神经元间的损失导致抑制和兴奋过程之间的不平衡,损害了皮质-纹状体-丘脑-皮质回路中运动程序的选择和过滤。GTS的治疗管理采用分步方法,以行为干预和药物治疗为一线策略。然而,脑深部电刺激(DBS)已成为一小部分严重、致残和治疗难治性痴呆患者的最后治疗选择。根据欧洲抽动秽语综合征研究学会(ESSTS)指南的定义,患者选择依赖于严格的多学科评估,包括抽动严重程度、功能损害和精神合并症的稳定性。虽然对照临床试验支持丘脑靶点(特别是中心体-束旁复合体)和苍白球靶点(如苍白球内)的相关性,但最近的研究已转向基于网络的视角和抽搐产生背后的振荡动力学特征。虽然持续开环刺激仍然是目前的临床标准,但前沿研究现在集中在适应性神经调节策略上。通过利用局部场电位(LFPs)的解码,可行性研究已经证明了电生理生物标志物的长期稳定性,为个性化、实时刺激范式铺平了道路。这些进展有望在最复杂和受影响最严重的GTS患者中优化DBS的收益-风险平衡。
期刊介绍:
Rédigé par des spécialistes à l''intention d''une Communauté pluridisciplinaire le Bulletin de l''Académie nationale de médecine est au service de toutes les professions médicales : médecins, pharmaciens, biologistes et vétérinaires ainsi que de l''Administration et des institutions intervenant dans le domaine de la santé.
Les mémoires originaux et les mises au point sur des thèmes d''actualité sont associés au compte rendu des discussions qui ont suivi leur présentation. Les rapports des commissions sur l''éthique médicale l''exercice de la profession les questions hospitalières la politique du médicament et l''enseignement de la médecine justifient les recommandations de l''Académie.